38 completed, 29 recruiting, 28 unknown, 13 active not recruiting. 46 Not applicable, 14 Phase 4, 12 Phase 2, 7 Phase 3, 6 Phase 1.
Follow HPV Infection: new trials by email Literature Review of HPV Infection trials Research Report on HPV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV Model 1- Screening in Clinic Only, Model 2 - Screening in Clinic and Community - Cervix Cancer, HIV Infections | Not applicable | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 17734 | 2026-09-01 | 2026-09-02 |
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya 5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 140 | 2026-09-01 | 2026-08-27 |
| Effect of EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid on HPV DNA Integration Epigallocatechin gallate (EGCG), Folic Acid (FA), Vitamin B12 (B12), and Hyaluronic Acid (HA) - HPV Infection, HPV Integration | Not applicable | Not yet recruiting | IRCCS San Raffaele | 42 | 2026-07-01 | 2026-07-13 |
| PRIORITY Study in Cervical Cancer Cervical Cancer, Cervical Intraepithelial Neoplasia | Not yet recruiting | Pontificia Universidad Catolica de Chile | 700 | 2026-06-30 | 2026-05-18 | |
| Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ pBI-11 (3 doses), pBI-11 (1 dose), Placebo (2 doses) - HPV Infection | Phase 2 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 48 | 2026-06-25 | 2026-07-01 |
| Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities EGCG and Quinine Sulfate Vaginal Suppository, Placebo - High-risk HPV (Any Strain), LSIL, Low Grade Squamous Intraepithelial Lesion | Phase 2 | Recruiting | Amplexd Therapeutics, Inc. | 45 | 2026-04-30 | 2026-05-14 |
| Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening Qualitative Interview, Virtual Visit Standard Instructions, Virtual Visit Standard Instructions + In-Person Registration Navigation - Cervical Cancer, HPV Infection | Not applicable | Recruiting | Washington University School of Medicine | 100 | 2026-04-17 | 2026-07-27 |
| Evaluation of the Effect of a Dietary Supplement Based on EGCG, Vitamin B12, Hyaluronic Acid, and Folic Acid on the Maintenance of Physiological Balance and the Natural Defenses of the Male Genital System in Subjects Exposed to HPV Infection. Pervistop - HPV Infection, Infertilities | Not applicable | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 96 | 2026-03-01 | 2026-01-15 |
| Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) Screen, Triage, and Treat - HIV Infections, HPV Infection | Not applicable | Recruiting | Columbia University | 600 | 2026-02-23 | 2026-02-25 |
| Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV Model 1- Screening in Clinic Only, Model 2 - Screening in Clinic and Community - Cervix Cancer, HIV Infections | Not applicable | Recruiting | UNC Lineberger Comprehensive Cancer Center | 7597 | 2026-02-03 | 2026-05-28 |
| Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years bivalent HPV vaccine, 9-valent HPV vaccine - HPV Infection | Phase 4 | Active not recruiting | Zhejiang Provincial Center for Disease Control and Prevention | 400 | 2025-12-20 | 2026-06-11 |
| Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer Q-Pad hrHPV Test System - HPV Infection, HPV 16 Infection | Not applicable | Recruiting | Qurasense | 450 | 2025-12-01 | 2026-07-24 |
| Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV anal swabbing - HPV Infection | Not applicable | Recruiting | Centre Hospitalier Universitaire de la Réunion | 398 | 2025-11-28 | 2025-12-11 |
| Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection No Intervention: Observational Cohort - Cervical Cancer Screening, HPV Infection | Recruiting | Karolinska Institutet | 130000 | 2025-10-31 | 2026-09-30 | |
| PopSci CHW4CervixHealth Evalyn® Brush, Copan Floqswab, CHW4CervicalHealth - Cervical Cancer, Hpv | Not applicable | Recruiting | Thomas Jefferson University | 120 | 2025-10-22 | 2026-08-11 |
| A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis Intravenous Leiomyomatosis, HPV Infection | Not yet recruiting | Peking Union Medical College Hospital | 30 | 2025-05-01 | 2025-02-28 | |
| Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use - HPV Infection | Early Phase 1 | Active not recruiting | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 20 | 2025-04-28 | 2026-05-20 |
| Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program mHealth - HPV Infection, Cervical Cancers | Not applicable | Not yet recruiting | University of Virginia | 3000 | 2025-04-15 | 2025-04-10 |
| Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial High-resolution anoscopy - HPV Infection, Anal Cancer | Not applicable | Recruiting | ANRS, Emerging Infectious Diseases | 100 | 2025-03-20 | 2025-12-04 |
| Hospital-based Validation of the New ELEVATE Screening Tool Questionnaire, HPV self-sample, Endocervical sample - Cervical Cancer, HPV Infection | Not applicable | Not yet recruiting | University Hospital, Ghent | 200 | 2025-03-01 | 2025-01-27 |
Showing 20 of 125. Sign in to see all of them.
Papillomavirus Infections (125) · Uterine Cervical Neoplasms (39) · HIV Infections (16) · Uterine Cervical Dysplasia (15) · Squamous Intraepithelial Lesions (7) · Anus Neoplasms (5) · Acquired Immunodeficiency Syndrome (3) · Condylomata Acuminata (3) · Neoplasms (3) · Atypical Squamous Cells of the Cervix (2) · Homosexuality (2) · Multiple Endocrine Neoplasia Type 1 (2) · Uterine Cervical Diseases (2) · Vaccine-Preventable Diseases (2) · Carcinoma in Situ (1)
Communicable Diseases (125) · DNA Virus Infections (125) · Disease Attributes (125) · Infections (125) · Pathologic Processes (125) · Pathological Conditions, Signs and Symptoms (125) · Tumor Virus Infections (125) · Urogenital Diseases (125) · Virus Diseases (125) · Genital Diseases (124) · Sexually Transmitted Diseases (124) · Sexually Transmitted Diseases, Viral (124) · Female Urogenital Diseases (50) · Female Urogenital Diseases and Pregnancy Complications (50) · Genital Diseases, Female (50)
Human Papillomavirus Recombinant Vaccine nonavalent (5) · Papillomavirus Vaccines (4) · artemisinin (3) · artesunic acid (3) · epigallocatechin gallate (3) · Colposcopy (2) · Cytological Techniques (2) · Educational Status (2) · Electrocoagulation (2) · Folic Acid (2) · Observation (2) · Vitamin B 12 (2) · artenimol (2) · Active Hexose Correlated Compound (1) · Artesunate (1)
Fujian Maternity and Child Health Hospital (7) · UNC Lineberger Comprehensive Cancer Center (4) · BlueSky Immunotherapies GmbH (3) · Duke University (3) · Frantz Viral Therapeutics, LLC (3) · National Vaccine and Serum Institute, China (3) · University of Washington (3) · Columbia University (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · International Agency for Research on Cancer (2) · Lee's Pharmaceutical Limited (2) · Monash University (2) · Peking Union Medical College Hospital (2) · Procare Health Iberia S.L. (2) · Shanghai Bovax Biotechnology Co., Ltd. (2)
China (20) · United States (19) · Italy (8) · France (6) · Kenya (6) · Spain (5) · Turkey (Türkiye) (4) · Australia (3) · Belgium (3) · Brazil (3) · Canada (3) · Uganda (3) · United Kingdom (3) · Austria (2) · Ecuador (2)
Lameck Chinula, MD (3) · Pengming Sun (3) · Aminur Rahman Shaheen, PhD (2) · Chemtai Mungo, MD MPH (2) · Chemtai Mungo, MD, MPH (2) · Grant Ellsworth, MD, MS (2) · Janine de Zeeuw, PhD (2) · Jennifer Smith, PhD (2) · Jennifer Tang, MD (2) · Katie Mollan, PhD (2) · Lisa Spees, PhD (2) · Megan Huchko, MD (2) · Michael Hudgens, PhD (2) · Pengming Sun, PhD (2) · Ting Huang (2)
PMID 33538338, PMID 41276263, PMID 11927495, PMID 14682443, PMID 15574793, PMID 17494925, PMID 17958849, PMID 18363746, PMID 18433504, PMID 18515521, PMID 19100537, PMID 19513123, PMID 19524035, PMID 19540281, PMID 19586656, PMID 20686382, PMID 21294779, PMID 22306855, PMID 23009652, PMID 23199966, PMID 23319742, PMID 23346264, PMID 23391351, PMID 23510764, PMID 23618600, PMID 23623831, PMID 23632723, PMID 23891022, PMID 24365799, PMID 24794396, PMID 25043222, PMID 25145486, PMID 25270519, PMID 26453270, PMID 26687616, PMID 28884125, PMID 29851256, PMID 30048762, PMID 30122563, PMID 30197061, PMID 30306310, PMID 30344281, PMID 30353714, PMID 30799413, PMID 30878235, PMID 30989655, PMID 31030590, PMID 32038557, PMID 32386620, PMID 32634066
U24CA275417 (2), U54CA242639 (2), UG1CA275403 (2), 2023 (1), D43TW009343 (1), P50CA098252 (1), R01CA240375 (1), R03DE033930 (1), R21CA236770 (1), R37CA306827 (1), U01AI069924 (1), U01CA269192 (1), U01CA275110 (1), UG1CA275412 (1), UG1CA284918 (1)